Click for best price
Shortacting B2 Agonists Market Size, Share 2024
The global Short-acting B2 Agonists market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Albuterol Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Short-acting B2 Agonists include Bayer AG, Teva, Roche, Viatris, GSK, Cipla Limited, Johnson & Johnson and Merck, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Short-acting B2 agonists (SABAs) are?albuterol, levalbuterol, metaproterenol, and terbutaline, and they are prescribed for bronchospasm caused by COPD, bronchial asthma, or emphysema.
This report aims to provide a comprehensive presentation of the global market for Short-acting B2 Agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short-acting B2 Agonists. This report contains market size and forecasts of Short-acting B2 Agonists in global, including the following market information:
- Global Short-acting B2 Agonists Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Short-acting B2 Agonists Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Short-acting B2 Agonists companies in 2023 (%)
We surveyed the Short-acting B2 Agonists manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Short-acting B2 Agonists Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Short-acting B2 Agonists Market Segment Percentages, by Type, 2023 (%)
- Albuterol
- Metaproterenol
- Levalbuterol
- Other
Global Short-acting B2 Agonists Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Short-acting B2 Agonists Market Segment Percentages, by Application, 2023 (%)
Global Short-acting B2 Agonists Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Short-acting B2 Agonists Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Short-acting B2 Agonists revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Short-acting B2 Agonists revenues share in global market, 2023 (%)
- Key companies Short-acting B2 Agonists sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Short-acting B2 Agonists sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer AG
- Teva
- Roche
- Viatris
- GSK
- Cipla Limited
- Johnson & Johnson
- Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Short-acting B2 Agonists, market overview.
Chapter 2: Global Short-acting B2 Agonists market size in revenue and volume.
Chapter 3: Detailed analysis of Short-acting B2 Agonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Short-acting B2 Agonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Short-acting B2 Agonists capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Short-acting B2 Agonists Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
73 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Short-acting B2 Agonists Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Short-acting B2 Agonists Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Short-acting B2 Agonists Overall Market Size
2.1 Global Short-acting B2 Agonists Market Size: 2023 VS 2030
2.2 Global Short-acting B2 Agonists Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Short-acting B2 Agonists Sales: 2019-2030
3 Company Landscape
3.1 Top Short-acting B2 Agonists Players in Global Market
3.2 Top Global Short-acting B2 Agonists Companies Ranked by Revenue
3.3 Global Short-acting B2 Agonists Revenue by Companies
3.4 Global Short-acting B2 Agonists Sales by Companies
3.5 Global Short-acting B2 Agonists Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Short-acting B2 Agonists Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Short-acting B2 Agonists Product Type
3.8 Tier 1, Tier 2 and Tier 3 Short-acting B2 Agonists Players in Global Market
3.8.1 List of Global Tier 1 Short-acting B2 Agonists Companies
3.8.2 List of Global Tier 2 and Tier 3 Short-acting B2 Agonists Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Short-acting B2 Agonists Market Size Markets, 2023 & 2030
4.1.2 Albuterol
4.1.3 Metaproterenol
4.1.4 Levalbuterol
4.1.5 Other
4.2 By Type - Global Short-acting B2 Agonists Revenue & Forecasts
4.2.1 By Type - Global Short-acting B2 Agonists Revenue, 2019-2024
4.2.2 By Type - Global Short-acting B2 Agonists Revenue, 2025-2030
4.2.3 By Type - Global Short-acting B2 Agonists Revenue Market Share, 2019-2030
4.3 By Type - Global Short-acting B2 Agonists Sales & Forecasts
4.3.1 By Type - Global Short-acting B2 Agonists Sales, 2019-2024
4.3.2 By Type - Global Short-acting B2 Agonists Sales, 2025-2030
4.3.3 By Type - Global Short-acting B2 Agonists Sales Market Share, 2019-2030
4.4 By Type - Global Short-acting B2 Agonists Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Short-acting B2 Agonists Market Size, 2023 & 2030
5.1.2 COPD
5.1.3 Asthma
5.1.4 Other
5.2 By Application - Global Short-acting B2 Agonists Revenue & Forecasts
5.2.1 By Application - Global Short-acting B2 Agonists Revenue, 2019-2024
5.2.2 By Application - Global Short-acting B2 Agonists Revenue, 2025-2030
5.2.3 By Application - Global Short-acting B2 Agonists Revenue Market Share, 2019-2030
5.3 By Application - Global Short-acting B2 Agonists Sales & Forecasts
5.3.1 By Application - Global Short-acting B2 Agonists Sales, 2019-2024
5.3.2 By Application - Global Short-acting B2 Agonists Sales, 2025-2030
5.3.3 By Application - Global Short-acting B2 Agonists Sales Market Share, 2019-2030
5.4 By Application - Global Short-acting B2 Agonists Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Short-acting B2 Agonists Market Size, 2023 & 2030
6.2 By Region - Global Short-acting B2 Agonists Revenue & Forecasts
6.2.1 By Region - Global Short-acting B2 Agonists Revenue, 2019-2024
6.2.2 By Region - Global Short-acting B2 Agonists Revenue, 2025-2030
6.2.3 By Region - Global Short-acting B2 Agonists Revenue Market Share, 2019-2030
6.3 By Region - Global Short-acting B2 Agonists Sales & Forecasts
6.3.1 By Region - Global Short-acting B2 Agonists Sales, 2019-2024
6.3.2 By Region - Global Short-acting B2 Agonists Sales, 2025-2030
6.3.3 By Region - Global Short-acting B2 Agonists Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Short-acting B2 Agonists Revenue, 2019-2030
6.4.2 By Country - North America Short-acting B2 Agonists Sales, 2019-2030
6.4.3 US Short-acting B2 Agonists Market Size, 2019-2030
6.4.4 Canada Short-acting B2 Agonists Market Size, 2019-2030
6.4.5 Mexico Short-acting B2 Agonists Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Short-acting B2 Agonists Revenue, 2019-2030
6.5.2 By Country - Europe Short-acting B2 Agonists Sales, 2019-2030
6.5.3 Germany Short-acting B2 Agonists Market Size, 2019-2030
6.5.4 France Short-acting B2 Agonists Market Size, 2019-2030
6.5.5 U.K. Short-acting B2 Agonists Market Size, 2019-2030
6.5.6 Italy Short-acting B2 Agonists Market Size, 2019-2030
6.5.7 Russia Short-acting B2 Agonists Market Size, 2019-2030
6.5.8 Nordic Countries Short-acting B2 Agonists Market Size, 2019-2030
6.5.9 Benelux Short-acting B2 Agonists Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Short-acting B2 Agonists Revenue, 2019-2030
6.6.2 By Region - Asia Short-acting B2 Agonists Sales, 2019-2030
6.6.3 China Short-acting B2 Agonists Market Size, 2019-2030
6.6.4 Japan Short-acting B2 Agonists Market Size, 2019-2030
6.6.5 South Korea Short-acting B2 Agonists Market Size, 2019-2030
6.6.6 Southeast Asia Short-acting B2 Agonists Market Size, 2019-2030
6.6.7 India Short-acting B2 Agonists Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Short-acting B2 Agonists Revenue, 2019-2030
6.7.2 By Country - South America Short-acting B2 Agonists Sales, 2019-2030
6.7.3 Brazil Short-acting B2 Agonists Market Size, 2019-2030
6.7.4 Argentina Short-acting B2 Agonists Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Short-acting B2 Agonists Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Short-acting B2 Agonists Sales, 2019-2030
6.8.3 Turkey Short-acting B2 Agonists Market Size, 2019-2030
6.8.4 Israel Short-acting B2 Agonists Market Size, 2019-2030
6.8.5 Saudi Arabia Short-acting B2 Agonists Market Size, 2019-2030
6.8.6 UAE Short-acting B2 Agonists Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Short-acting B2 Agonists Major Product Offerings
7.1.4 Bayer AG Short-acting B2 Agonists Sales and Revenue in Global (2019-2024)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Teva
7.2.1 Teva Company Summary
7.2.2 Teva Business Overview
7.2.3 Teva Short-acting B2 Agonists Major Product Offerings
7.2.4 Teva Short-acting B2 Agonists Sales and Revenue in Global (2019-2024)
7.2.5 Teva Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Short-acting B2 Agonists Major Product Offerings
7.3.4 Roche Short-acting B2 Agonists Sales and Revenue in Global (2019-2024)
7.3.5 Roche Key News & Latest Developments
7.4 Viatris
7.4.1 Viatris Company Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Short-acting B2 Agonists Major Product Offerings
7.4.4 Viatris Short-acting B2 Agonists Sales and Revenue in Global (2019-2024)
7.4.5 Viatris Key News & Latest Developments
7.5 GSK
7.5.1 GSK Company Summary
7.5.2 GSK Business Overview
7.5.3 GSK Short-acting B2 Agonists Major Product Offerings
7.5.4 GSK Short-acting B2 Agonists Sales and Revenue in Global (2019-2024)
7.5.5 GSK Key News & Latest Developments
7.6 Cipla Limited
7.6.1 Cipla Limited Company Summary
7.6.2 Cipla Limited Business Overview
7.6.3 Cipla Limited Short-acting B2 Agonists Major Product Offerings
7.6.4 Cipla Limited Short-acting B2 Agonists Sales and Revenue in Global (2019-2024)
7.6.5 Cipla Limited Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Short-acting B2 Agonists Major Product Offerings
7.7.4 Johnson & Johnson Short-acting B2 Agonists Sales and Revenue in Global (2019-2024)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Short-acting B2 Agonists Major Product Offerings
7.8.4 Merck Short-acting B2 Agonists Sales and Revenue in Global (2019-2024)
7.8.5 Merck Key News & Latest Developments
8 Global Short-acting B2 Agonists Production Capacity, Analysis
8.1 Global Short-acting B2 Agonists Production Capacity, 2019-2030
8.2 Short-acting B2 Agonists Production Capacity of Key Manufacturers in Global Market
8.3 Global Short-acting B2 Agonists Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Short-acting B2 Agonists Supply Chain Analysis
10.1 Short-acting B2 Agonists Industry Value Chain
10.2 Short-acting B2 Agonists Upstream Market
10.3 Short-acting B2 Agonists Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Short-acting B2 Agonists Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Short-acting B2 Agonists in Global Market
Table 2. Top Short-acting B2 Agonists Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Short-acting B2 Agonists Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Short-acting B2 Agonists Revenue Share by Companies, 2019-2024
Table 5. Global Short-acting B2 Agonists Sales by Companies, (K Units), 2019-2024
Table 6. Global Short-acting B2 Agonists Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Short-acting B2 Agonists Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Short-acting B2 Agonists Product Type
Table 9. List of Global Tier 1 Short-acting B2 Agonists Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Short-acting B2 Agonists Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Short-acting B2 Agonists Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Short-acting B2 Agonists Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Short-acting B2 Agonists Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Short-acting B2 Agonists Sales (K Units), 2019-2024
Table 15. By Type - Global Short-acting B2 Agonists Sales (K Units), 2025-2030
Table 16. By Application ? Global Short-acting B2 Agonists Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Short-acting B2 Agonists Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Short-acting B2 Agonists Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Short-acting B2 Agonists Sales (K Units), 2019-2024
Table 20. By Application - Global Short-acting B2 Agonists Sales (K Units), 2025-2030
Table 21. By Region ? Global Short-acting B2 Agonists Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Short-acting B2 Agonists Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Short-acting B2 Agonists Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Short-acting B2 Agonists Sales (K Units), 2019-2024
Table 25. By Region - Global Short-acting B2 Agonists Sales (K Units), 2025-2030
Table 26. By Country - North America Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Short-acting B2 Agonists Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Short-acting B2 Agonists Sales, (K Units), 2019-2024
Table 29. By Country - North America Short-acting B2 Agonists Sales, (K Units), 2025-2030
Table 30. By Country - Europe Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Short-acting B2 Agonists Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Short-acting B2 Agonists Sales, (K Units), 2019-2024
Table 33. By Country - Europe Short-acting B2 Agonists Sales, (K Units), 2025-2030
Table 34. By Region - Asia Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Short-acting B2 Agonists Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Short-acting B2 Agonists Sales, (K Units), 2019-2024
Table 37. By Region - Asia Short-acting B2 Agonists Sales, (K Units), 2025-2030
Table 38. By Country - South America Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Short-acting B2 Agonists Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Short-acting B2 Agonists Sales, (K Units), 2019-2024
Table 41. By Country - South America Short-acting B2 Agonists Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Short-acting B2 Agonists Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Short-acting B2 Agonists Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Short-acting B2 Agonists Sales, (K Units), 2025-2030
Table 46. Bayer AG Company Summary
Table 47. Bayer AG Short-acting B2 Agonists Product Offerings
Table 48. Bayer AG Short-acting B2 Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Bayer AG Key News & Latest Developments
Table 50. Teva Company Summary
Table 51. Teva Short-acting B2 Agonists Product Offerings
Table 52. Teva Short-acting B2 Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Teva Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Short-acting B2 Agonists Product Offerings
Table 56. Roche Short-acting B2 Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Roche Key News & Latest Developments
Table 58. Viatris Company Summary
Table 59. Viatris Short-acting B2 Agonists Product Offerings
Table 60. Viatris Short-acting B2 Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Viatris Key News & Latest Developments
Table 62. GSK Company Summary
Table 63. GSK Short-acting B2 Agonists Product Offerings
Table 64. GSK Short-acting B2 Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. GSK Key News & Latest Developments
Table 66. Cipla Limited Company Summary
Table 67. Cipla Limited Short-acting B2 Agonists Product Offerings
Table 68. Cipla Limited Short-acting B2 Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Cipla Limited Key News & Latest Developments
Table 70. Johnson & Johnson Company Summary
Table 71. Johnson & Johnson Short-acting B2 Agonists Product Offerings
Table 72. Johnson & Johnson Short-acting B2 Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Johnson & Johnson Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Short-acting B2 Agonists Product Offerings
Table 76. Merck Short-acting B2 Agonists Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Merck Key News & Latest Developments
Table 78. Short-acting B2 Agonists Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 79. Global Short-acting B2 Agonists Capacity Market Share of Key Manufacturers, 2022-2024
Table 80. Global Short-acting B2 Agonists Production by Region, 2019-2024 (K Units)
Table 81. Global Short-acting B2 Agonists Production by Region, 2025-2030 (K Units)
Table 82. Short-acting B2 Agonists Market Opportunities & Trends in Global Market
Table 83. Short-acting B2 Agonists Market Drivers in Global Market
Table 84. Short-acting B2 Agonists Market Restraints in Global Market
Table 85. Short-acting B2 Agonists Raw Materials
Table 86. Short-acting B2 Agonists Raw Materials Suppliers in Global Market
Table 87. Typical Short-acting B2 Agonists Downstream
Table 88. Short-acting B2 Agonists Downstream Clients in Global Market
Table 89. Short-acting B2 Agonists Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Short-acting B2 Agonists Segment by Type in 2023
Figure 2. Short-acting B2 Agonists Segment by Application in 2023
Figure 3. Global Short-acting B2 Agonists Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Short-acting B2 Agonists Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Short-acting B2 Agonists Revenue, 2019-2030 (US$, Mn)
Figure 7. Short-acting B2 Agonists Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Short-acting B2 Agonists Revenue in 2023
Figure 9. By Type - Global Short-acting B2 Agonists Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Short-acting B2 Agonists Revenue Market Share, 2019-2030
Figure 11. By Type - Global Short-acting B2 Agonists Sales Market Share, 2019-2030
Figure 12. By Type - Global Short-acting B2 Agonists Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Short-acting B2 Agonists Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Short-acting B2 Agonists Revenue Market Share, 2019-2030
Figure 15. By Application - Global Short-acting B2 Agonists Sales Market Share, 2019-2030
Figure 16. By Application - Global Short-acting B2 Agonists Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Short-acting B2 Agonists Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Short-acting B2 Agonists Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Short-acting B2 Agonists Revenue Market Share, 2019-2030
Figure 20. By Region - Global Short-acting B2 Agonists Sales Market Share, 2019-2030
Figure 21. By Country - North America Short-acting B2 Agonists Revenue Market Share, 2019-2030
Figure 22. By Country - North America Short-acting B2 Agonists Sales Market Share, 2019-2030
Figure 23. US Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Short-acting B2 Agonists Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Short-acting B2 Agonists Sales Market Share, 2019-2030
Figure 28. Germany Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 29. France Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Short-acting B2 Agonists Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Short-acting B2 Agonists Sales Market Share, 2019-2030
Figure 37. China Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 41. India Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Short-acting B2 Agonists Revenue Market Share, 2019-2030
Figure 43. By Country - South America Short-acting B2 Agonists Sales Market Share, 2019-2030
Figure 44. Brazil Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Short-acting B2 Agonists Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Short-acting B2 Agonists Sales Market Share, 2019-2030
Figure 48. Turkey Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Short-acting B2 Agonists Revenue, (US$, Mn), 2019-2030
Figure 52. Global Short-acting B2 Agonists Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Short-acting B2 Agonists by Region, 2023 VS 2030
Figure 54. Short-acting B2 Agonists Industry Value Chain
Figure 55. Marketing Channels
